|
The information for the additional 510k is as follows: g5.Pma / 510(k)#: k020322, k021954, k022172, k023273, k023301, k024152, k030677, k031306, k031589, k031679, k032131, k033784, k033907, k040006, k040106, k040716, k050555, k051689, k053241, k060214, k060217, k060218, k060493, k070809, k082538, k082852, and k131331.H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Investigation summary: this complaint is for high mic vancomycin (va) with staphylococcus aureus when using phoenix panel pmic-108 (catalog number 448418) batch number 3213323.The customer did not provide phoenix generated lab reports, isolates or panel returns for the investigation.To investigate, two retention panels of the complaint batch were inoculated with qc isolate s.Aureus a29213 and placed in a phoenix m50 for va mic results.In addition, one control panel from the same material but different batch was inoculated with qc isolate s.Aureus a29213 and placed in a phoenix m50 for va mic result.Results of the investigation returned all panels with the expected mic for va with s.Aureus.This complaint is not confirmed.The batch history record was satisfactory, and no quality notifications were generated during manufacturing and inspection.Complaint trending was performed, and no trends were identified associated with this defect.Bd will continue to monitor for trends and take action as necessary.Please continue to communicate any additional concerns.
|